HORNBILL: a phase I/IIa trial examining the safety, tolerability and early response of BI 764524 in patients with diabetic retinopathy and diabetic macular ischaemia-rationale, study design and protocol.
Ngai Victor ChongQuan Dong NguyenYasir SepahAndrea GianiElizabeth PearcePublished in: Trials (2022)
ClinicalTrials.gov NCT04424290 ; EudraCT 2019-004432-28. Registered on 9 June 2020.